GCAR1 (GPNMB-targeting CAR T-Cell Therapy)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for GCAR1 (GPNMB-targeting CAR T-Cell Therapy), covering 2026-03-23 to 2026-03-23. Get the full timeline:
Most recent: Clinical Trial Update: GPNMB-targeting Chimeric Antigen Receptor T-Cell Therapy (GCAR1) for a Patient With Alveolar Soft Part Sarcoma (CLIC-YYC-GPNMB-02) [EARLY_Phase 1]